ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Shareholders’ equity 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) shareholders’ equity at each fiscal year-end, per SEC filings.
$466.1MFY2025 · since FY2016: $95.6M → $466.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $466.1M | +151.3% |
| FY2024 | $185.4M | -31.7% |
| FY2023 | $271.3M | -31.9% |
| FY2022 | $398.5M | -2.5% |
| FY2021 | $408.8M | -11.5% |
| FY2020 | $461.8M | +88.8% |
| FY2019 | $244.6M | +155.3% |
| FY2018 | $95.8M | +17.7% |
| FY2017 | $81.4M | -14.8% |
| FY2016 | $95.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice